Loading clinical trials...
Loading clinical trials...
Ablation of Intestinal Metaplasia Containing Dysplasia (AIM Dysplasia Trial) A Multi-center, Randomized, Sham-Controlled Trial: Protocol Amendment to Extend Follow-up to 5 Years
Conditions
Interventions
Ablation System plus anti-secretory medication
Sham procedure plus anti-secretory medication
Locations
19
United States
Mayo Clinic Scottsdale
Scottsdale, Arizona, United States
University of Arizona, VAMC
Tucson, Arizona, United States
UC Irvine Medical Center
Orange, California, United States
Mayo Clinic - Jacksonville
Jacksonville, Florida, United States
Harvard, VA Boston Healthcare W Roxbury
West Roxbury, Massachusetts, United States
Mayo Clinic Rochester
Rochester, Minnesota, United States
Start Date
February 1, 2006
Primary Completion Date
April 1, 2014
Completion Date
August 1, 2014
Last Updated
November 6, 2017
NCT05753748
NCT06746623
NCT05056051
NCT05706025
NCT00431756
NCT02521285
Lead Sponsor
Medtronic - MITG
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions